One of the most important problems to solve in the treatment of a disease is to find out how to measure its status in the person. In order to do that you need a biomarker to measure. For example, we take a blood test to measure cholesterol. If it is higher than normal, the physician can prescribe a diet and medication to treat it. Then, measure it again to see if it is working.
Well, for Parkinson’s we didn’t have a biomarker. Diagnosis and progression of PD have been mostly measured subjectively with various visual tests by a neurologist. Something objective, like a biomarker, would be huge improvement. This year all that has changed when it was announced that a biomarker was discovered, and a test developed.
Finding a biomarker for this disease is a huge scientific breakthrough. It’s one that the Parkinson’s community has been waiting for and the MJFF has been working on for over a decade and one my guest has been working on for just about 10 years. She will explain how it was discovered, what is involved in the testing process and why we all should care.
Don’t miss this episode. It’s good news. https://www.michaeljfox.org/news/breaking-news-parkinsons-disease-biomarker-found https://www.michaeljfox.org/ppmi https://www.dbsandme.com/en.html Thank you to my sponsor, Boston Scientific, the maker of Vercise Genus, a Deep Brain Stimulation or DBS system. To learn more about Parkinson’s treatment options, please visit DBSandMe.com.